First Affiliated Hospital Of Wenzhou Medical University
Clinical trials sponsored by First Affiliated Hospital Of Wenzhou Medical University, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could a cancer drug slow lung scarring? new trial tests anlotinib for IPF Results expected Sep 2026 (estimated)
- Can AI predict who will respond to liver cancer drugs? Results expected Dec 2026 (estimated)
- Common nausea pill may tame immunotherapy's harsh side effects in liver cancer Results expected Dec 2026 (estimated)
- Radiation plus Chemo-Immunotherapy shows promise in High-Risk breast cancer trial Results expected Dec 2026 (estimated)
- New combo aims to slow lung scarring in IPF patients Results expected Mar 2027 (estimated)
-
New model predicts prostate cancer treatment response using PET scans
Knowledge-focused CompletedThis study looked at 168 men with metastatic hormone-sensitive prostate cancer to see if a model using PSMA-PET scans and routine medical information could predict how well they would respond to standard first-line treatment. The goal was to help doctors better understand which p…
Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Scientists map cancer spread in low rectal tumors to guide surgeons
Knowledge-focused CompletedThis study looked at how ultralow rectal cancer spreads within the bowel wall in 106 patients. The goal was to understand the pattern of spread to help surgeons decide how much tissue to remove during surgery. By learning these patterns, doctors hope to create more personalized t…
Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC